Clinicopathological features of Churg-Strauss syndrome-associated neuropathy

被引:156
作者
Hattori, N
Ichimura, M
Nagamatsu, M
Li, M
Yamamoto, K
Kumazawa, K
Mitsuma, T
Sobue, G [1 ]
机构
[1] Nagoya Univ, Sch Med, Dept Neurol, Nagoya, Aichi 4668550, Japan
[2] Aichi Med Univ, Div Neurol, Dept Internal Med 4, Nagakute, Aichi, Japan
关键词
Churg-Strauss syndrome; vasculitic neuropathy; corticosteroids; T-cell infiltration; prognosis;
D O I
10.1093/brain/122.3.427
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We assessed the clinicopathological features of 28 patients with peripheral neuropathy associated with Churg-Strauss syndrome. Initial symptoms attributable to neuropathy were acute painful dysaesthesiae and oedema in the dysaesthetic portion of the distal limbs. Sensory and motor involvement mostly showed a pattern of mononeuritis multiplex in the initial phase, progressing into asymmetrical polyneuropathy, restricted to the limbs. Parallel loss of myelinated and unmyelinated fibres due to axonal degeneration was evident as decreased or absent amplitudes of sensory nerve action potentials and compound muscle action potentials, indicating acute massive axonal loss. Epineurial necrotizing vasculitis was seen in 54% of cases; infiltrates consisted mainly of CD8-positive suppressor/cytotoxic and CD4-positive helper T lymphocytes. Eosinophils were present in infiltrates, but in smaller numbers than lymphocytes. CD20-positive B lymphocytes were seen only occasionally. Deposits of IgG, C3d, IgE and major basic protein were scarce. The mean follow-up period was 4.2 years, with a range of 8 months to 10 years. Fatal outcome was seen only in a single patient, indicating a good survival rate. The patients who responded well to the initial corticosteroid therapy within 4 weeks regained self-controlled functional status in longterm follow-up (modified Rankin score was less than or equal to 2), while those not responding well to the initial corticosteroid therapy led a dependent existence (P < 0.01), In addition the patients with poor functional outcomes had significantly more systemic organ damage caused by vasculitis (P < 0.05), Necrotizing vasculitis mediated by cytotoxic T cells, leading to ischaemic changes, appears to be a major cause of Churg-Strauss syndrome-associated neuropathy, The initial clinical course and the extent of systemic vasculitic lesions may influence the long-term functional prognosis.
引用
收藏
页码:427 / 439
页数:13
相关论文
共 50 条
  • [1] Clinicopathological studies of peripheral neuropathy in Churg-Strauss syndrome
    Nagashima, T
    Cao, BZ
    Takeuchi, N
    Chuma, T
    Mano, Y
    Fujimoto, M
    Nunomura, M
    Oshikiri, T
    Miyazaki, K
    Dohke, M
    Kashimura, N
    Shinohara, T
    Orba, Y
    Ishizawa, S
    Nagashima, K
    NEUROPATHOLOGY, 2002, 22 (04) : 299 - 307
  • [2] Remarkable effect of anticoagulation therapy in Churg-Strauss syndrome-associated neuropathy: a case report
    Takahashi, T.
    Kikuchi, A.
    Kuroda, H.
    Fujihara, K.
    Itoyama, Y.
    EUROPEAN JOURNAL OF NEUROLOGY, 2006, 13 (07) : E12 - E12
  • [3] Clinical characterization and successful treatment of 6 patients with Churg-Strauss syndrome-associated neuropathy
    Nakamura, Masakazu
    Yabe, Ichiro
    Yaguchi, Hiroaki
    Kishimoto, Riichiro
    Mito, Yasunori
    Fujiki, Naoto
    Houzen, Hideki
    Tsuji-Akimoto, Sachiko
    Niino, Masaaki
    Sasaki, Hidenao
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2009, 111 (08) : 683 - 687
  • [4] A case of cutaneous sensory neuropathy associated with Churg-Strauss syndrome
    Gomes, C
    L'heveder, G
    Vandhuick, O
    Mabin, D
    Saraux, A
    JOINT BONE SPINE, 2003, 70 (01) : 73 - 76
  • [5] Churg-Strauss syndrome
    Guillevin, L
    Pagnoux, C
    Cohen, P
    REVUE FRANCAISE D ALLERGOLOGIE ET D IMMUNOLOGIE CLINIQUE, 2004, 44 (01): : 96 - 102
  • [6] Churg-Strauss syndrome-associated heart failure and left ventricular thrombosis
    Liori, Sotiria
    Samiotis, Eleftherios
    Birba, Dionysia
    Katsimbri, Pelagia
    Mademli, Maria
    Bakola, Eleni
    Tsivgoulis, Georgios
    Quris, Estela
    Bonios, Michael
    Kalabaliki, Maria
    Farmakis, Dimitrios
    Parissis, John
    Frogoudaki, Alexandra
    ESC HEART FAILURE, 2023, 10 (03): : 2107 - 2112
  • [7] Churg-Strauss syndrome
    Zwerina, J.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2008, 67 (02): : 137 - 144
  • [8] Mortality and morbidity in peripheral neuropathy associated Churg-Strauss syndrome and microscopic polyangiitis
    Hattori, N
    Mori, K
    Misu, K
    Koike, H
    Ichimura, M
    Sobue, G
    JOURNAL OF RHEUMATOLOGY, 2002, 29 (07) : 1408 - 1414
  • [9] Clinicopathological Features of Churg-Strauss Syndrome With Severe Nerve Degeneration: A Case Report
    Xiang, Jing Yan
    Zhao, Yu Wu
    Fu, Jian Liang
    Cheng, Xiao Juan
    Xue, Qin
    Wang, Yin
    MEDICINA-LITHUANIA, 2012, 48 (05): : 244 - 248
  • [10] Churg-Strauss syndrome associated with montelukast
    Mukhopadhyay, A
    Stanley, NN
    POSTGRADUATE MEDICAL JOURNAL, 2001, 77 (908) : 390 - 391